Sorafenib-treated hepatocellular carcinoma with or without prior direct-acting antiviral therapy for hepatitis C: outcomes and survival by Rania Lithy, Mohamed Kohla, Hossam Dabees, Hend Ibrahim Shousha, Ehab Fawzy, Eman M. F. Barakat, Mohamed El-Kassas, Mona Shoukry Aziz, Eman Elkhateeb, Ashraf Omar Abdelaziz, Mohamed Omar Abdelmalek, Ali Azmy, Ahmed Tawheed, Reem Abdelghafour, Hossam Taha, Mohamed Mahmoud Nabeel, Mohamed A. Medhat, Dalia Ghoraba, Hamdy Sayed, Anwar Nassief, Mostafa Elhelbawy, Tamer Elbaz, Ahmed Radwan, Safaa Ragab Askar, Eman Marwan, Eman Rewisha, Ahmed Hosni Abdelmaksoud, Sayed Hassan Ahmed, Nevien Fouad Elfouly, Nermeen Abdeen, Ahmed Ramadan, Asmaa A. Abdeltawab, Mostafa Abd Alfattah Shamkh, Yasser Arafat Abdelrazek, Ammar Alrajhi, Sayed Ahmed Sayed, Ahmed A. Sleem, Rasha Salah Hussein, Allam Elsayed Allam, Omnia A. Seyam, Mohamed Said, representing The Egyptian Network for the Study of H. C. C. (ENSH) group

Get full text